GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (FRA:1FW2) » Definitions » FCF Yield %

WuXi Biologics (Cayman) (FRA:1FW2) FCF Yield % : 2.17 (As of Apr. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, WuXi Biologics (Cayman)'s Trailing 12-Month Free Cash Flow is €147 Mil, and Market Cap is €6,682 Mil. Therefore, WuXi Biologics (Cayman)'s FCF Yield % for today is 2.17%.

The historical rank and industry rank for WuXi Biologics (Cayman)'s FCF Yield % or its related term are showing as below:

FRA:1FW2' s FCF Yield % Range Over the Past 10 Years
Min: -2.21   Med: -0.96   Max: 2.17
Current: 2.17


During the past 10 years, the highest FCF Yield % of WuXi Biologics (Cayman) was 2.17%. The lowest was -2.21%. And the median was -0.96%.

FRA:1FW2's FCF Yield % is ranked better than
91.35% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs FRA:1FW2: 2.17

WuXi Biologics (Cayman)'s FCF Margin % for the quarter that ended in Jun. 2023 was 2.30%.


WuXi Biologics (Cayman) FCF Yield % Historical Data

The historical data trend for WuXi Biologics (Cayman)'s FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) FCF Yield % Chart

WuXi Biologics (Cayman) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.78 -1.20 -1.01 -0.15 -

WuXi Biologics (Cayman) Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 -0.94 0.80 0.27 -

Competitive Comparison of WuXi Biologics (Cayman)'s FCF Yield %

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WuXi Biologics (Cayman)'s FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s FCF Yield % distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s FCF Yield % falls into.



WuXi Biologics (Cayman) FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

WuXi Biologics (Cayman)'s FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-44.239 / 30409.19622
=-0.15%

WuXi Biologics (Cayman)'s annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=25.177 * 2 / 18549.08198
=0.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WuXi Biologics (Cayman) FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


WuXi Biologics (Cayman) FCF Yield % Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


WuXi Biologics (Cayman) (FRA:1FW2) Business Description

Address
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (FRA:1FW2) Headlines

No Headlines